Skip to content

Vitamin K uptake in chronic kidney disease

Vitamin K uptake in chronic kidney disease - VitK-uremia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025281
Enrollment
20
Registered
2021-05-26
Start date
2018-02-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers N18

Interventions

Group 1: Uptake of different vitamin K forms after a single oral administration of vitamin K1 and menaquinones-4 and -7

Sponsors

Universitätsklinikum der RWTH Aachen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: stable, chronic hemodialysis patients •Age of = 18 years •Written informed consent prior to study participation •The subject is willing and able to follow the procedures outlined in the protocol Control group: •Normal renal function •Age- and sex-matched written informed consent prior to study participation •The subject is willing and able to follow the procedures outlined in the protocol

Exclusion criteria

Exclusion criteria: •Age less than 18 years •Severe medical events within the last three months •Planned surgery for the duration of the sampling •Acute/chronic gastrointestinal infections •Recent or ongoing antibiotic therapy •Conditions that impair vitamin K uptake or metabolism (chronic inflammatory bowel disease, intake of vitamin K antagonists) •Smokers •Severe dyslipidemia •Severe anemia, defined as hemoglobin level less than 9.0 g/dl

Design outcomes

Primary

MeasureTime frame
Determination of vitamin K content in liporoteins until 6 hrs after ingestion

Countries

Germany

Contacts

Public ContactJürgen Floege

Universitätsklinik der RWTH AachenMedizinische Klinik II

nkaesler@ukaachen.de0241-8089530

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026